|
UBR7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.739200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.004800E-01 |
| Normal-vs-Stage2 |
4.511400E-01 |
| Normal-vs-Stage3 |
3.801200E-01 |
| Normal-vs-Stage4 |
9.338200E-01 |
| Stage1-vs-Stage2 |
5.559800E-01 |
| Stage1-vs-Stage3 |
5.359400E-01 |
| Stage1-vs-Stage4 |
9.236400E-01 |
| Stage2-vs-Stage3 |
9.672000E-01 |
| Stage2-vs-Stage4 |
7.002000E-01 |
| Stage3-vs-Stage4 |
6.898200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.097400E-01 |
| Normal-vs-AfricanAmerican |
6.179600E-02 |
| Normal-vs-Asian |
9.703200E-01 |
| Caucasian-vs-AfricanAmerican |
6.205600E-02 |
| Caucasian-vs-Asian |
9.014600E-01 |
| AfricanAmerican-vs-Asian |
4.924000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.489000E-01 |
| Normal-vs-Female |
1.007180E-01 |
| Male-vs-Female |
1.571560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.178600E-01 |
| Normal-vs-Extreme_Weight |
9.292800E-01 |
| Normal-vs-Obese |
4.691800E-02 |
| Normal-vs-Extreme_Obese |
9.249600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.891600E-01 |
| Normal_Weight-vs-Obese |
5.762300E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.273000E-01 |
| Extreme_Weight-vs-Obese |
6.460000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.946800E-01 |
| Obese-vs-Extreme_Obese |
3.261000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.748030E-01 |
| Normal-vs-Age(41-60Yrs) |
2.681700E-02 |
| Normal-vs-Age(61-80Yrs) |
5.661400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.767400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.474800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.556300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.381240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.397500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.831370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.848200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.335830E-01 |
| Normal-VS-Type2 PRCC |
2.471400E-01 |
| Normal-VS-KIRP CIMP |
4.916000E-01 |
| Normal-VS-Unclassified PRCC |
1.356790E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.388360E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.417600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.046200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.568410E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.193500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.292000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.194400E-01 |
| Normal-vs-N1 |
3.896800E-01 |
| Normal-vs-N2 |
4.385000E-03 |
| N0-vs-N1 |
2.252000E-01 |
| N0-vs-N2 |
7.663800E-02 |
| N1-vs-N2 |
3.942100E-03 |
|
|
